[HTML][HTML] Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma
C Blattmann, S Oertel, D Schulz-Ertner, S Rieken… - BMC cancer, 2010 - Springer
Background Osteosarcoma is the most common primary malignant bone tumor in children
and adolescents. For effective treatment, local control of the tumor is absolutely critical …
and adolescents. For effective treatment, local control of the tumor is absolutely critical …
Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma
C Blattmann, S Oertel, D Schulz-Ertner, S Rieken… - BMC …, 2010 - search.proquest.com
Background: Osteosarcoma is the most common primary malignant bone tumor in children
and adolescents. For effective treatment, local control of the tumor is absolutely critical …
and adolescents. For effective treatment, local control of the tumor is absolutely critical …
Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma
C Blattmann, S Oertel, D Schulz-Ertner, S Rieken… - BMC Cancer, 2010 - hero.epa.gov
BACKGROUND: Osteosarcoma is the most common primary malignant bone tumor in
children and adolescents. For effective treatment, local control of the tumor is absolutely …
children and adolescents. For effective treatment, local control of the tumor is absolutely …
Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma
C Blattmann, S Oertel, D Schulz-Ertner, S Rieken… - BMC Cancer, 2010 - go.gale.com
Background Osteosarcoma is the most common primary malignant bone tumor in children
and adolescents. For effective treatment, local control of the tumor is absolutely critical …
and adolescents. For effective treatment, local control of the tumor is absolutely critical …
[PDF][PDF] Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma
C Blattmann, S Oertel, D Schulz-Ertner, S Rieken… - 2010 - academia.edu
Background: Osteosarcoma is the most common primary malignant bone tumor in children
and adolescents. For effective treatment, local control of the tumor is absolutely critical …
and adolescents. For effective treatment, local control of the tumor is absolutely critical …
[HTML][HTML] Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma
C Blattmann, S Oertel, D Schulz-Ertner… - BMC …, 2010 - bmccancer.biomedcentral.com
Osteosarcoma is the most common primary malignant bone tumor in children and
adolescents. For effective treatment, local control of the tumor is absolutely critical, because …
adolescents. For effective treatment, local control of the tumor is absolutely critical, because …
[PDF][PDF] Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma
C Blattmann, S Oertel, D Schulz-Ertner, S Rieken… - 2010 - d-nb.info
Background: Osteosarcoma is the most common primary malignant bone tumor in children
and adolescents. For effective treatment, local control of the tumor is absolutely critical …
and adolescents. For effective treatment, local control of the tumor is absolutely critical …
[PDF][PDF] Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma
C Blattmann, S Oertel, D Schulz-Ertner, S Rieken… - 2010 - Citeseer
Background: Osteosarcoma is the most common primary malignant bone tumor in children
and adolescents. For effective treatment, local control of the tumor is absolutely critical …
and adolescents. For effective treatment, local control of the tumor is absolutely critical …
[引用][C] Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma
C Blattmann, S Oertel, D Schulz-Ertner, S Rieken… - BMC Cancer, 2010 - cir.nii.ac.jp
Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy
in patients with non-resectable osteosarcoma | CiNii Research CiNii 国立情報学研究所 学術 …
in patients with non-resectable osteosarcoma | CiNii Research CiNii 国立情報学研究所 学術 …
Non-randomized therapy trial to determine the safety and efficacy of heavy ion radiotherapy in patients with non-resectable osteosarcoma.
C Blattmann, S Oertel, D Schulz-Ertner, S Rieken… - BMC Cancer, 2010 - europepmc.org
Background Osteosarcoma is the most common primary malignant bone tumor in children
and adolescents. For effective treatment, local control of the tumor is absolutely critical …
and adolescents. For effective treatment, local control of the tumor is absolutely critical …